Fol. Biol. 2008, 54, 88-96
https://doi.org/10.14712/fb2008054030088
Frequency of Representative Single Nucleotide Polymorphisms Associated with Inflammatory Bowel Disease in the Czech Republic and Slovak Republic
References
1. 2005) Crohn’s disease patients carrying Nod2/ CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann. Surg. 242, 693-700.
< , M., Arostegui, J. I., Sans, M., Tassies, D., Plaza, S., Delgado, S., Lacy, A. M., Pique, J. M., Yagüe, J., Panés, J. (https://doi.org/10.1097/01.sla.0000186173.14696.ea>
2. 2005) New concepts in the pathophysiology of inflammatory bowel disease. Ann. Intern. Med. 143, 895-904.
< , G., Nyce, M., R., de la Rue, S., A., Cominelli, F. (https://doi.org/10.7326/0003-4819-143-12-200512200-00007>
3. 2003) The genetics of inflammatory bowel disease. Gastroenterology 124, 521-536.
< , D. K., Cho, J. H. (https://doi.org/10.1053/gast.2003.50045>
4. 2005) Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn’s disease patients. J. Mol. Med. 83, 601-609.
< , H., Stokkers, P., Hommes, T., Cohl, D., Vogels, E., Pronk, I., Spek, A., van Kampen, A., van Deventer, S., Peppelenbosch, M., Hommes, D. (https://doi.org/10.1007/s00109-005-0685-x>
5. 2001) Polymorphisms on the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status. Clin. Immunol. 101, 357-360.
< , C., Zahn, R., Martin, K., Albert, E., Folwaczny, C. (https://doi.org/10.1006/clim.2001.5118>
6. 2006) Family and twin studies in inflammatory bowel disease. World J. Gastroenterol. 23, 3668-3672.
< , L., Paavola-Sakki, P., Turunen, U., Lappalainen, M., Färkkilä, M., Kontula, K. (https://doi.org/10.3748/wjg.v12.i23.3668>
7. 2001) Polymorphism of CC chemokine receptors CCR2 and CCR5 in Crohn’s disease. Immunol. Lett. 77, 113-117.
< , H., Pollok-Kopp, B., Göke, M., Press, A., Oppermann, M. (https://doi.org/10.1016/S0165-2478(01)00199-7>
8. 1996) Mapping of susceptibility locus for Crohn’s disease on chromosome 16. Nature 379, 821-823.
< , J. P., Laurent-Pulg, P., Gower-Rousseau, C., Olson, J. M., Lee, J. C., Beaugerie, L., Naom, I., Dupas, J. L., van Gossum, A., Groupe d’Etude Thérapeutique des Affections Inflammatoires Digestives, Orholm, M., Bonalti-Pellie, C., Weissenbach, J., Mathew, C. G., Lennard-Jones, J. E., Cortot, A., Colombel, J. F., Thomas, G. (https://doi.org/10.1038/379821a0>
9. 2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn‘s disease. Nature 411, 599-603.
< , J. P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J. P, Belaiche, J., Almer, S., Tysk, C., O‘Morain, C. A., Gassull, M., Binder, V., Finkel, Y., Cortot, A., Modigliani, R., Laurent-Puig, P., Gower-Rousseau, C., Macry, J., Colombel, J. F., Sahbatou, M., Thomas, G. (https://doi.org/10.1038/35079107>
10. 2005) Carriage of CARD15 variants and smoking as risk factors for resective surgery in patients with Crohn’s ileal disease. Aliment. Pharmacol. Ther. 22, 557-564.
< , L., Costa, S., Saibeni, S., Bianchi, P., Omodei, P., Carrara, A., Spina, L., Contessini Avesani, E., Vecchi, M., de Franchiss, R., Malesci, A. (https://doi.org/10.1111/j.1365-2036.2005.02629.x>
11. 2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet. 70, 845-857.
< , S., Zouali, H., Cézard, J.-P. and the EPWG-IBD group, Colombel, J.-F. and the EPIMAD group, Belaiche, J. and the GETAID group, Almer, S., Tysk, C., O’Morain, C., Gassull, M., Binder, V., Finkel, Y., Modigliani, R., Gower-Rousseau, C., Macry, J., Merlin, F., Chamaillard, M., Jannot, A.-S., Thomas, G., Hugot, J.-P. (https://doi.org/10.1086/339432>
12. 2004) Inflammatory bowel disease is linked to 19p13 and associated with ICAM-1. Inflamm. Bowel Dis. 10, 173-181.
< , J. H., Williams, F. A., Yang, X., Cullen, S., Colley, J., Ling, K. L., Armuzzi, A., Ahmad, T., Neville, M. J., Dechairo, B. M., Walton, R., Lench, N. J., Jewell, D. P. (https://doi.org/10.1097/00054725-200405000-00001>
13. Lukáš, M. (2003) Granulomatous colitis and ulcerous colitis. In: Medical Repetitorium, ed. Houdek, L., pp. 294-296, Galén, Praha. (in Czech)
14. 2004) Genetics of inflammatory bowel disease: progress and prospects. Hum. Mol. Genet. 13, R161–R168.
< , C. G., Lewis, C. M. (https://doi.org/10.1093/hmg/ddh079>
15. 2003) Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in a Japanese population. Gut 52, 75-78.
< , J., Sugimura, K., Matsuda, Y., Takazoe, M., Ishizuka, T., Mochizuki, T., Seki, S. S., Yoneyama, O., Bannnai, H., Suzuki, K., Honma, T., Asakura, H. (https://doi.org/10.1136/gut.52.1.75>
16. 2005) The geographic spread of the CCR5 D32 HIV-resistance allele. PLoS Biol. 3, e339.
< , J., Galvani, A. P., Slatkin, M. (https://doi.org/10.1371/journal.pbio.0030339>
17. 2001a) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J. Biol. Chem. 276, 4812-4818.
< , Y., Inohara, N., Benito, A., Chen, F. F., Yamaoka, S., Núñez, G. (https://doi.org/10.1074/jbc.M008072200>
18. 2001b) A frameshift mutation in NOD2 associated with susceptibility to Crohn‘s disease. Nature 411, 603-606.
< , Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., Achkar, J. P., Brant, S. R., Bayless, T. M., Kirschner, B. S., Hanauer, S. B., Nunez, G., Cho, J. H. (https://doi.org/10.1038/35079114>
19. 2005) Accumulation of CCR5+ T cells around RANTES+ granulomas in Crohn’s disease: a pivotal site of Th1-shifted immune response? Lab. Invest. 85, 137-145.
< , M., Ohtani, H., Kinouchi, Y., Sato, E., Nakamura, S., Matsumoto, T., Nagura, H., Yoshie, O., Shimosegawa, T. (https://doi.org/10.1038/labinvest.3700189>
20. 1991) Familial occurrence of inflammatory bowel disease. N. Engl. J. Med. 324, 84-88.
< , M., Munkholm, P., Langholz, E., Nielsen, O. H., Sorensen, T. I., Binder, V. (https://doi.org/10.1056/NEJM199101103240203>
21. 2006) NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease. J. Gastroenterol. 41, 304-310.
< , S. C., Dağli, Ü., Kiliç, M. Y., Törüner, M., Çelik, Y., Özkan, M., Soykan, I., Çetinkaya, H., Ülker, A., Özden, A., Bozdayi, A. M. (https://doi.org/10.1007/s00535-005-1780-z>
22. 2004) Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease. Dig. Liver Dis. 36, 528-532.
< , A., Pola, R., Flex, A., Danese, S., Armuzzi, A., Gaetani, E., Guidi, L., De Vitis, I., Urgesi, R., Grillo, A., Serricchio, M., Proia, A. S., Fedeli, G., Gasbarrini, G., Pola, P., Gasbarrini, A. (https://doi.org/10.1016/j.dld.2004.03.015>
23. 2003) Role of Nod2 in the response of macrophages to Toll-like receptor agonists. Mol. Cell. Biol. 23, 7531-7539.
< , A. L., Murray, P. J. (https://doi.org/10.1128/MCB.23.21.7531-7539.2003>
24. 2002) Inflammatory bowel disease. N. Engl. J. Med. 347, 417-429.
< , D. K. (https://doi.org/10.1056/NEJMra020831>
25. 1998) Crohns disease in Slovakia: Prevalence, socioeconomic and psychological analysis. Eur. J. Epidemiol. 14, 49-53.
< , M., Letkovicova, M., Matejickova, V. (https://doi.org/10.1023/A:1007490213432>
26. 2000) The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18, 593-620.
< , F., Mackay, C. R., Lanzavecchia, A. (https://doi.org/10.1146/annurev.immunol.18.1.593>
27. 1990) Adhesion receptors of the immune system. Nature 346, 425-434.
< , T. A. (https://doi.org/10.1038/346425a0>
28. 1994) Polymorphisms and linkage analysis for ICAM-1 and the selectin gene cluster. Genomics 21, 473-477.
< , D. K., Rosenbloom, C. L., Beaudet, A. L., Cottingham, R. W. (https://doi.org/10.1006/geno.1994.1303>
29. 2005) NOD2 in Crohn’s disease – loss or gain of funtion mutation? Neth. J. Med. 63, 286-287.
, Z., Stokkers, P., Hommes, D. W. (